Aborted radical prostatectomy (RP) still affects 5% of contemporary North American patients. It confers a significant survival disadvantage that was quantified in 13.5% higher cancer-specific mortality rate, which appears to apply even to patients with baseline prostate-specific antigen values up to 50 ng/ml and with up to seven lymph node metastases. An emphasis on the persistent rate of aborted RP is warranted, with the intent of further decreasing or ultimately eliminating such clinical practice.
Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients
Marchioni M.;
2019-01-01
Abstract
Aborted radical prostatectomy (RP) still affects 5% of contemporary North American patients. It confers a significant survival disadvantage that was quantified in 13.5% higher cancer-specific mortality rate, which appears to apply even to patients with baseline prostate-specific antigen values up to 50 ng/ml and with up to seven lymph node metastases. An emphasis on the persistent rate of aborted RP is warranted, with the intent of further decreasing or ultimately eliminating such clinical practice.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
